Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 3
2021 5
2022 10
2023 16
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness.
Tchouaket MCT, Fokam J, Sosso SM, Semengue ENJ, Yagai B, Simo RK, Sando Z, Nka AD, Tchinda GP, Takou D, Fainguem N, Chenwi C, Ka'e AC, Abba A, Zam MKN, Perno CF, Colizzi V, Ndjolo A. Tchouaket MCT, et al. Among authors: semengue enj. IJID Reg. 2022 Oct 6;5:130-136. doi: 10.1016/j.ijregi.2022.09.014. eCollection 2022 Dec. IJID Reg. 2022. PMID: 36313603 Free PMC article.
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.
Fokam J, Chenwi CA, Tala V, Takou D, Santoro MM, Teto G, Dambaya B, Anubodem F, Semengue ENJ, Beloumou G, Djupsa S, Assomo E, Fokunang C, Alteri C, Billong S, Bouba NP, Ajeh R, Colizzi V, Mbanya D, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: semengue enj. Viruses. 2023 Jun 28;15(7):1458. doi: 10.3390/v15071458. Viruses. 2023. PMID: 37515146 Free PMC article.
The 2nd International Conference on Public Health in Africa 12-15 December 2022, Kigali Rwanda.
Colizzi V, Fokam J, Semengue ENJ, Deutou L, Durand Nka A, Tommo M, Fainguem N, Gouissi H, Malimbou E, Etame NK, Mangala C, Muwonge A, Mahamat A, Mbacham W, Leke R, Ndembi N. Colizzi V, et al. Among authors: semengue enj. J Public Health Afr. 2023 Mar 28;14(2):2625. doi: 10.4081/jphia.2023.2625. eCollection 2023 Feb 28. J Public Health Afr. 2023. PMID: 37065814 Free PMC article. No abstract available.
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.
Nka AD, Bouba Y, Teto G, Semengue ENJ, Takou DK, Ngueko AMK, Fabeni L, Carioti L, Armenia D, Pabo W, Dambaya B, Sosso SM, Colizzi V, Perno CF, Ceccherini-Silberstein F, Santoro MM, Fokam J, Ndjolo A. Nka AD, et al. Among authors: semengue enj. J Antimicrob Chemother. 2022 Dec 23;78(1):272-275. doi: 10.1093/jac/dkac388. J Antimicrob Chemother. 2022. PMID: 36411257
Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis.
Ka'e AC, Nanfack A, Santoro MM, Yagai B, Ambada G, Sagnia B, Nka AD, Ngoufack Jagni Semengue E, Pabo W, Takou D, Sonela N, Colizzi V, Perno CF, Ceccherini-Silberstein F, Lewin SR, Tiemessen CT, Fokam J. Ka'e AC, et al. Among authors: ngoufack jagni semengue e. BMJ Open. 2023 Oct 10;13(10):e073672. doi: 10.1136/bmjopen-2023-073672. BMJ Open. 2023. PMID: 37816567 Free PMC article.
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model.
Semengue ENJ, Fokam J, Etame NK, Molimbou E, Chenwi CA, Takou D, Mossiang L, Meledie AP, Yagai B, Nka AD, Dambaya B, Teto G, Ka'e AC, Beloumou GA, Djupsa Ndjeyep SC, Abba A, Kengni AMN, Tommo Tchouaket MC, Bouba NP, Billong SC, Sosso SM, Colizzi V, Perno CF, Kouanfack C, Zoung-Kanyi Bissek AC, Eben-Moussi E, Santoro MM, Ceccherini-Silberstein F, Ndjolo A. Semengue ENJ, et al. Viruses. 2022 Dec 21;15(1):18. doi: 10.3390/v15010018. Viruses. 2022. PMID: 36680058 Free PMC article.
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings.
Fokam J, Ngoufack Jagni Semengue E, Molimbou E, Etame NK, Santoro MM, Takou D, Mossiang L, Meledie AP, Chenwi CA, Yagai B, Nka AD, Dambaya B, Teto G, Ka'e AC, Beloumou GA, Ndjeyep SCD, Fainguem N, Abba A, Kengni AMN, Tchouaket MCT, Bouba NP, Billong SC, Djubgang R, Saounde ET, Sosso SM, Kouanfack C, Bissek AZ, Eben-Moussi E, Colizzi V, Perno CF, Ceccherini-Silberstein F, Ndjolo A. Fokam J, et al. Among authors: ngoufack jagni semengue e. Microbiol Spectr. 2022 Dec 21;10(6):e0342022. doi: 10.1128/spectrum.03420-22. Epub 2022 Oct 19. Microbiol Spectr. 2022. PMID: 36259973 Free PMC article.
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.
Fokam J, Ngoufack Jagni Semengue E, Armenia D, Takou D, Dambaya B, Teto G, Chenwi CA, Nka AD, Beloumou GA, Ndjeyep SCD, Tchouaket MCT, Fainguem N, Sosso SM, Colizzi V, Perno CF, Ndjolo A, Ceccherini-Silberstein F, Santoro MM. Fokam J, et al. Among authors: ngoufack jagni semengue e. Diagn Microbiol Infect Dis. 2022 Feb;102(2):115574. doi: 10.1016/j.diagmicrobio.2021.115574. Epub 2021 Oct 22. Diagn Microbiol Infect Dis. 2022. PMID: 34864527
42 results